Rakuten Securities, Inc.
Broker-DealerPosition in LNTH — Lantheus Holdings, Inc.
CIK 2009539
TOKYO, M0
Position in LNTH
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,550
+$1,123 QoQ
Shares Held
32
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#419
of 462 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LNTH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Rakuten Securities, Inc. holds $507,039 across 7 Drug Manufacturers - Specialty & Generic names. LNTH ranks #4 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
12,784 | $443,221 | |
| 2 | ZTS |
Zoetis Inc.
|
626 | $44,984 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
21 | $11,378 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
This page
|
32 | $3,550 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
11 | $1,853 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
40 | $1,355 | |
| 7 | VTRS |
Viatris Inc
|
44 | $698 |
All Filings in LNTH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,550 | 32 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $2,427 | 32 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $4,924 | 74 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $4,308 | 84 | Shares | Defined | 2025-10-28 | |
| 2025-06-30 | $7,940 | 97 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $8,003 | 82 | Shares | Defined | 2025-04-18 | |
| 2024-12-31 | $4,473 | 50 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $3,292 | 30 | Shares | Defined | 2024-11-05 | |
| No filing history on record for this holder in this stock. | ||||||